Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation.
about
Animal models of COPD: What do they tell us?Multiple biomarkers predict disease severity, progression and mortality in COPD.A Systematic Review of Diagnostic Biomarkers of COPD Exacerbation.Proteoglycan 4 is a diagnostic biomarker for COPD.COPD Exacerbation Biomarkers Validated Using Multiple Reaction Monitoring Mass Spectrometry.B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review.C-reactive protein and N-terminal prohormone brain natriuretic peptide as biomarkers in acute exacerbations of COPD leading to hospitalizations.High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study.Serum Uric Acid Levels and Uric Acid/Creatinine Ratios in Stable Chronic Obstructive Pulmonary Disease (COPD) Patients: Are These Parameters Efficient Predictors of Patients at Risk for Exacerbation and/or Severity of Disease?Factors associated with plasma IL-33 levels in patients with chronic obstructive pulmonary diseaseNetwork-based analysis reveals novel gene signatures in peripheral blood of patients with chronic obstructive pulmonary disease.Acute exacerbations of COPD: risk factors for failure and relapse.Systemic White Blood Cell Count as a Biomarker for Chronic Obstructive Pulmonary Disease: Utility and LimitationsThe Challenges of Precision Medicine in COPD.A hybrid multibreath wash-in wash-out lung function quantification scheme in human subjects using hyperpolarized 3 He MRI for simultaneous assessment of specific ventilation, alveolar oxygen tension, oxygen uptake, and air trapping.Precision medicine in COPD: where are we and where do we need to go?
P2860
Q28066451-B10510EA-72E2-4396-A86D-5D34D5DC335CQ33796180-E8AC23AC-4AAB-4B73-85E6-1DD1AD94D59FQ36081606-6F2C1327-1F5C-41EA-8F64-10E9DD3B6E28Q36093278-C038D0A4-0E0B-4E63-B3AA-7A6FF1018E9BQ36104051-C234ACDC-35EE-4D7B-95BE-E5F49F206156Q36245755-5DEDCC60-E4DF-4920-8301-6723F6AE12D9Q36318334-FE2DFAFB-B8FF-4E2C-9B3D-7F5B35E242C8Q37311290-15143B78-AFAA-4E68-936D-35A435A3BC2AQ37398571-22E8693F-9BD1-41B7-8385-A6CA41DD28E9Q37608553-64B57226-CB10-42B4-9294-593B6E964C65Q38377587-F9F6B2F3-E587-40A1-A2DF-1CDC98E88548Q41072489-9D226AF3-E94F-4158-89D3-6DC7DD5E7761Q42337197-8FD600A8-4403-4504-9DBB-81E7239BB4D5Q47962475-B4CD450B-3F50-41A2-BEE1-B5B3F920D17DQ48774551-73F9EB54-D354-4C93-B954-42DEC8AABA93Q58804231-88C4E565-43A2-470C-88BF-A1BA93315FAF
P2860
Biomarker Development for Chronic Obstructive Pulmonary Disease. From Discovery to Clinical Implementation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Biomarker Development for Chro ...... ry to Clinical Implementation.
@en
Biomarker Development for Chro ...... ry to Clinical Implementation.
@nl
type
label
Biomarker Development for Chro ...... ry to Clinical Implementation.
@en
Biomarker Development for Chro ...... ry to Clinical Implementation.
@nl
prefLabel
Biomarker Development for Chro ...... ry to Clinical Implementation.
@en
Biomarker Development for Chro ...... ry to Clinical Implementation.
@nl
P2093
P2860
P1476
Biomarker Development for Chro ...... ry to Clinical Implementation.
@en
P2093
Bruce M McManus
Mari L DeMarco
Raymond T Ng
Zsuzsanna Hollander
P2860
P304
P356
10.1164/RCCM.201505-0871PP
P407
P577
2015-07-15T00:00:00Z